18.04.2018 Views

MDF Magazine Newsletter Issue 55 April 2018

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

National<br />

First of its kind outside the<br />

borders of the United States<br />

By Gerda Brown<br />

We are happy to announce that on 27 October 2017, the Muscular Dystrophy<br />

Foundation of South Africa (MDSA) awarded the status of Global Certified<br />

Duchenne Care Center to the Red Cross War Memorial Children’s Hospital in Cape<br />

Town. This certification is the first of its kind outside the borders of the United<br />

States and confirms that the Duchenne-specific patient care and services provided<br />

at this centre are provided in agreement with international standards. To retain the<br />

certification, the Red Cross Hospital must satisfy the MDSA that the agreed level of care is being maintained. We are hopeful<br />

that, with this recognition, South Africa will now have access to early therapeutic interventions as part of Duchenne clinical<br />

trials. In the past, South African clinics were not considered viable due to the perception that we had limited resources.<br />

During August and September 2016 the Muscular Dystrophy Foundation was fortunate in hosting representatives from Parent<br />

Project Muscular Dystrophy (a Duchenne-specific organisation based in the United States) to present lectures about Duchenne<br />

muscular dystrophy to our South African families and clinicians. Parent Project Muscular Dystrophy (PPMD) is recognised<br />

around the world as the leader in the Duchenne community. Because of their efforts, families affected by Duchenne have<br />

better access to state-of-the-art care information and research. This visit led to the neuromuscular service, based at Red Cross<br />

War Memorial Children’s Hospital, to apply for certification by the PPMD as a Certified Duchenne Care Center.<br />

Muscular dystrophy (MD) is the name given to a group of more than 70 different neuromuscular disorders causing progressive<br />

wasting and weakness of the muscles. Each type presents differently and with its own levels of complexity. The prognosis<br />

varies according to the type of MD and the speed of progression. Some types are mild and progress very slowly, allowing<br />

normal life expectancy, while others are more severe and result in functional disability and loss of the ability to walk. The<br />

disorders are usually inherited, with the defective gene being passed on from one generation to the next. However, MD can<br />

also occur in families where there is no prior history of the condition.<br />

Duchenne muscular dystrophy (Duchenne) is the most serious neuromuscular genetic disorder diagnosed in childhood.<br />

Because the Duchenne gene is found on the X-chromosome, it primarily affects boys. Duchenne results in progressive<br />

loss of strength and is caused by a mutation in the gene that<br />

encodes for dystrophin. Because dystrophin is absent, the<br />

muscles gradually break down. The progressive muscle<br />

weakness leads to serious medical problems, particularly<br />

issues relating to the heart and lungs. Young men with<br />

Duchenne typically lose the ability to walk between the ages<br />

of 10 and 14 years and live only into their late twenties.<br />

About the Muscular Dystrophy Foundation of South Africa (www.mdsa.org.za)<br />

The Muscular Dystrophy Foundation of South Africa is a registered non-profit organisation consisting of a National Office<br />

and three branches which operate in the nine provinces of South Africa. The Foundation was founded in 1974 by Mr and Mrs<br />

Walker, who at the time had a son affected with Duchenne Muscular Dystrophy. The Foundation was established with the aim<br />

of reaching out to other parents and families in a similar situation and to support research into this disease with the ultimate<br />

goal of finding a cure.<br />

About the Global Certified Duchenne Care Center Program<br />

Created by Parent Project Muscular Dystrophy (PPMD) in the US, the Global Certified Duchenne Care Center (CDCC)<br />

Program offers a path forward for global neuromuscular patient advocacy groups to certify Duchenne Care Centers within<br />

their own countries. Patient advocacy groups, operating within their own country and under the guidance of Parent Project<br />

Muscular Dystrophy’s Certified Duchenne Care Center Program, grant certification to local Duchenne Care Centers that meet<br />

the high standards set forth by this program. Learn more online at EndDuchenne.org/CareCenters.<br />

6

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!